INGN Key Statistics, Chart & Performance
The current stock price of INGN is 6.94 USD. In the past month the price decreased by -1.28%. In the past year, price decreased by -26.95%.
INGN Latest News, Press Relases and Analysis
INGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.07 | 217.50B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.82 | 203.96B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.06 | 144.57B | ||
| SYK | STRYKER CORP | 27.64 | 139.21B | ||
| IDXX | IDEXX LABORATORIES INC | 56.63 | 57.02B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.54 | 50.02B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.62 | 38.93B | ||
| RMD | RESMED INC | 25.91 | 37.45B | ||
| DXCM | DEXCOM INC | 35.21 | 25.54B | ||
| PODD | INSULET CORP | 66.63 | 21.42B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.65 | 18.68B |
Related stock screener links
About INGN
Company Profile
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Company Info
INOGEN INC
859 Ward Drive
Goleta CALIFORNIA 93117 US
CEO: Nabil Shabshab
Employees: 766
Phone: 18055620500
INOGEN INC / INGN FAQ
What does INGN do?
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
What is the stock price of INOGEN INC today?
The current stock price of INGN is 6.94 USD. The price decreased by -0.72% in the last trading session.
Does INOGEN INC pay dividends?
INGN does not pay a dividend.
How is the ChartMill rating for INOGEN INC?
INGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in INOGEN INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INGN.
What is INOGEN INC worth?
INOGEN INC (INGN) has a market capitalization of 188.42M USD. This makes INGN a Micro Cap stock.
When does INOGEN INC (INGN) report earnings?
INOGEN INC (INGN) will report earnings on 2026-02-23, after the market close.
INGN Technical Analysis
INGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INGN. While INGN seems to be doing ok healthwise, there are quite some concerns on its profitability.
INGN Financial Highlights
Over the last trailing twelve months INGN reported a non-GAAP Earnings per Share(EPS) of -0.94. The EPS increased by 58.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.27% | ||
| ROE | -12.87% | ||
| Debt/Equity | 0 |
INGN Forecast & Estimates
8 analysts have analysed INGN and the average price target is 13.26 USD. This implies a price increase of 91.07% is expected in the next year compared to the current price of 6.94.
For the next year, analysts expect an EPS growth of 36.25% and a revenue growth 7.88% for INGN